These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23910054)

  • 1. Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillation.
    Cannon C; Ezekowitz MD; Granger C
    Am J Cardiol; 2013 Aug; 112(4):S3. PubMed ID: 23910054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention in atrial fibrillation patients.
    Marinigh R; Lip GY; Lane DA
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
    Yu HC; Tsai YF; Chen MC; Yeh CH
    Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 16. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].
    García Escrivà A; López Hernández N; Hernández Lorido R; Oliver Navarrete C; Bustos S; Carneado Ruiz J; Gracia Fleta F; Moltó Jordá JM
    Rev Neurol; 2004 Mar 1-15; 38(5):401-5. PubMed ID: 15029514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation therapy in paroxysmal atrial fibrillation].
    Risøe C; Gjesdal K
    Tidsskr Nor Laegeforen; 2004 Apr; 124(7):950-2. PubMed ID: 15060644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New frontiers for stroke prevention in atrial fibrillation.
    Prasad V; Kaplan RM; Passman RS
    Cerebrovasc Dis; 2012; 33(3):199-208. PubMed ID: 22261539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.